目的探讨一种治疗肝硬化门脉高压症的术式。
Objective to search for an operation method which can treat hepatocirrhosis and portal hypertension.
目的胆管手术合并肝硬化门脉高压症的临床研究。
Objective To study bile duct operation and portal hypertension.
探讨强肝软坚方对肝硬化门脉高压症的作用及其可能机制。
To study the effect of Qianggan Ruanjian decoction (QRD) on hepatocirrhosis portal hypertension and its possible function mechanism.
目的：探讨甲氰咪胍对肝硬化门脉高压症犬门脉血液动力学的影响。
Objective To investigate the effects of Cimetidine on portal hemodynamics in dogs with cirrhosis and portal hypertension.
方法回顾性分析本中心23例肝脏移植肝硬化门脉高压症患者的临床资料。
Methods Clinical data of 23 patients with portal hypertension who underwent orthotropic liver transplantation (OLT) were studied retrospectively.
结论脾大部切除脾大网膜腹膜后固定术是治疗肝硬化门脉高压症的一种理想术式。
Conclusion It is an ideal operation method in the treatment of hepatocirrhosis and portal hypertension.
目的 ：比较丹参、硝苯啶联用与各药单用治疗肝硬化门脉高压症的血流动力学变化。
Objective:To compare the effects of salvia and nifedipine on hemodynamics in patients with liver cirrhosis and portal hypertension by using doppler ultrasound.
目的：探讨光量子血氧疗法（UBIO）在肝硬化门脉高压症术后肝损伤治疗中的应用。
Objective: To study the effect of ultraviolet blood irradiation and oxygenation(UBIO)on liver trauma after operation for symptom of hepatocirrhosis portal hypertension.
结论检测肝硬化门脉高压症患者的肝组织NO含量、NOS活性可预测其肝脏损伤程度。
Detecting the level of NO and the activity of NOS of patients with hepatic portal hypertension can predict the degree of liver injury.
方法：在肝硬化门脉高压症行脾切除，断流术的同时制作一腹膜管，使腹水经此管转流于皮下。
Method To make a peritoneum canal at the meantime splenectomy and cut off stream, the ascites flow in the subdermal via the peritoneum.
④不论是正常还是肝硬化门脉高压症大鼠脾脏都具有免疫功能，应视具体情况尽可能保留脾脏。
These findings indicate that either in the normal or in the cirrhosis rats the spleen works functionally and should be preserved as far as possible according to its actual situation.
方法收集124例肝硬化门脉高压症住院患者的资料，对照分析导致出血的诱因，总结预见性护理方法。
Methods There were 124 cases of portal hypertension patients, comparative analysis with the bleeding factors and sum up the methods of the predictive nursing.
静息性的肝硬化可能在出现因门脉高压引起的充血性脾肿大导致的无症状的血小板减少症之后才被发现。
Silent cirrhosis may be discovered after the finding of asymptomatic thrombocytopenia caused by the congestive splenomegaly of portal hypertension .
目的探讨门静脉营养在治疗肝硬化、门脉高压症中的作用。
Objective To explore the effects of portal nutrition on liver cirrhosis and portal hypertension.
目的：探讨肝硬化、门脉高压症行脾切除术后早期应用抗凝药物对预防门静脉血栓的意义。
Objective To research the anticoagulants in protecting the portal vein obstruction after splenectomy due to the portal hypertension of hepatic cirrhosis.
《国际肝病》：门脉高压及其并发症如静脉曲张出血，腹水和肝性脑病在肝硬化患者较常见。
International Digest: Portal hypertension and its complications such as variceal hemorrhage, ascites, and encephalopathy are common in cirrhosis.
病人患有肝硬化和门脉高压症，很可能会发生肝性胸水，最常见的是右侧单侧胸腔积液。
The diagnosis of hepatic hydrothorax should be suspected in a patient with established cirrhosis and portal hypertension, presenting with a unilateral pleural effusion, most commonly right-sided.
结论：EVL联合PSE方法简单、安全，对肝硬化所致的门脉高压症近期疗效确切。
Conclusion: The combination of EVL and PSE is safe and simple. Its recent curative effect on portal hypertension due to cirrhosis is definite.
肝硬化；幽门螺杆菌；消化性溃疡；门脉高压；内毒素血症。
Liver cirrhosis; Helicobacter pylori; Pepetic ulcer; Portal hypertension; Endotoxemia.
肝硬化；幽门螺杆菌；消化性溃疡；门脉高压；内毒素血症。
Liver cirrhosis; Helicobacter pylori; Pepetic ulcer; Portal hypertension; Endotoxemia.
应用推荐